Galangin

Galangin is a lipid of Polyketides (PK) class. Galangin is associated with abnormalities such as Morphologically altered structure and Wiskott-Aldrich Syndrome. The involved functions are known as Apoptosis, Metabolic Inhibition, Cell Proliferation, Process and Proliferation (morphologic abnormality). Galangin often locates in Microsomes, Liver, Cytoplasmic matrix, Microsomes, Protoplasm and Tissue membrane. The associated genes with Galangin are CYP1A1 gene, CYP1A2 gene, WNT3A gene, ALPP gene and TCF7L2 gene. The related lipids are Promega.

Cross Reference

Introduction

To understand associated biological information of Galangin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Galangin?

Galangin is suspected in Morphologically altered structure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Galangin

MeSH term MeSH ID Detail
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Urination Disorders D014555 9 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Brain Ischemia D002545 89 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 12

PubChem Associated disorders and diseases

What pathways are associated with Galangin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Galangin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Galangin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Galangin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Galangin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Galangin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Galangin

Download all related citations
Per page 10 20 50 100 | Total 345
Authors Title Published Journal PubMed Link
Jacobson KA et al. Interactions of flavones and other phytochemicals with adenosine receptors. 2002 Adv. Exp. Med. Biol. pmid:12083460
Otake Y et al. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. 2002 Drug Metab. Dispos. pmid:11950790
Matsui T et al. Luteolin, a flavone, does not suppress postprandial glucose absorption through an inhibition of alpha-glucosidase action. 2002 Biosci. Biotechnol. Biochem. pmid:12005074
Denny BJ et al. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. 2002 FEMS Microbiol. Lett. pmid:11934488
Otake Y and Walle T Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. 2002 Drug Metab. Dispos. pmid:11792676
Borrelli F et al. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. 2002 Fitoterapia pmid:12495710
Heijnen CG et al. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. 2001 Toxicol In Vitro pmid:11259863
Liu LX et al. Vancomycin resistance reversal in enterococci by flavonoids. 2001 J. Pharm. Pharmacol. pmid:11206187
Kajiya K et al. Role of lipophilicity and hydrogen peroxide formation in the cytotoxicity of flavonols. 2001 Biosci. Biotechnol. Biochem. pmid:11440146
Raso GM et al. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. 2001 Life Sci. pmid:11213362
Boumendjel A et al. B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance. 2001 Bioorg. Med. Chem. Lett. pmid:11140738
Lee SE et al. Inhibitory effects of naturally occurring compounds on aflatoxin B(1) biotransformation. 2001 J. Agric. Food Chem. pmid:11714299
Heo MY et al. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. 2001 Mutat. Res. pmid:11344041
Heijnen CG et al. Peroxynitrite scavenging of flavonoids: structure activity relationship. 2001 Environ. Toxicol. Pharmacol. pmid:21782577
Quadri SA et al. The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis. 2000 Mol. Pharmacol. pmid:10953044
Kubo I et al. Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. 2000 Bioorg. Med. Chem. pmid:10976523
Imamura Y et al. Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. 2000 J. Biochem. pmid:10739958
Kaneko T and Baba N Protective effect of flavonoids on endothelial cells against linoleic acid hydroperoxide-induced toxicity. 1999 Biosci. Biotechnol. Biochem. pmid:10192914
Ciolino HP and Yeh GC The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. 1999 Br. J. Cancer pmid:10188874
Krizková L et al. The effect of flavonoids on ofloxacin-induced mutagenicity in Euglena gracilis. 1998 Mutat. Res. pmid:9725994
Zhai S et al. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes. 1998 Life Sci. pmid:9718089
Sohn SJ et al. Antigenotoxicity of galangin against N-methyl-N-nitrosourea. 1998 Mutat. Res. pmid:9675294
Jiang Q et al. Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors. 1997 J. Med. Chem. pmid:9258366
Meyer JJ et al. Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens. 1997 J Ethnopharmacol pmid:9174978
Afolayan AJ and Meyer JJ The antimicrobial activity of 3,5,7-trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. 1997 J Ethnopharmacol pmid:9292410
Silva ID et al. Metabolism of galangin by rat cytochromes P450: relevance to the genotoxicity of galangin. 1997 Mutat. Res. pmid:9393617
Uda Y et al. Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids. 1997 Cancer Lett. pmid:9461039
Karton Y et al. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. 1996 J. Med. Chem. pmid:8691424
Critchfield JW et al. Inhibition of HIV activation in latently infected cells by flavonoid compounds. 1996 AIDS Res. Hum. Retroviruses pmid:8825617
So FV et al. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. 1996 Nutr Cancer pmid:8875554
Heo MY et al. Anticlastogenic effects of galangin against mitomycin C-induced micronuclei in reticulocytes of mice. 1996 Mutat. Res. pmid:8657208
Chieli E et al. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. 1995 Life Sci. pmid:7475916
Green MD et al. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. 1994 Sep-Oct Drug Metab. Dispos. pmid:7835232
Critchfield JW et al. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. 1994 Biochem. Pharmacol. pmid:7945444
Heo MY et al. Anticlastogenic effects of galangin against bleomycin-induced chromosomal aberrations in mouse spleen lymphocytes. 1994 Mutat. Res. pmid:7526187
Pomilio AB et al. Antimicrobial constituents of Gomphrena martiana and Gomphrena boliviana. 1992 J Ethnopharmacol pmid:1608273
Brinkworth RI et al. Flavones are inhibitors of HIV-1 proteinase. 1992 Biochem. Biophys. Res. Commun. pmid:1445308
Spedding G et al. Inhibition of reverse transcriptases by flavonoids. 1989 Antiviral Res. pmid:2480745
Pepeljnjak S et al. Flavonoid content in propolis extracts and growth inhibition of Bacillus subtilis. 1985 Pharmazie pmid:3923500
Carver JH et al. Genetic effects of the flavonols quercetin, kaempferol, and galangin on Chinese hamster ovary cells in vitro. 1983 Mutat. Res. pmid:6828043
Koru O et al. In vitro antimicrobial activity of propolis samples from different geographical origins against certain oral pathogens. Anaerobe pmid:17475517
Ristivojević P et al. Ultrahigh-performance liquid chromatography and mass spectrometry (UHPLC-LTQ/Orbitrap/MS/MS) study of phenolic profile of Serbian poplar type propolis. Phytochem Anal pmid:25376949
pmid:
Cvek J et al. Optimisation of an extraction procedure and chemical characterisation of Croatian propolis tinctures. Phytochem Anal pmid:17624905
Popova M et al. Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Anal pmid:15311843